R. Sapierzyński

951 total citations
88 papers, 676 citations indexed

About

R. Sapierzyński is a scholar working on Pulmonary and Respiratory Medicine, Small Animals and Surgery. According to data from OpenAlex, R. Sapierzyński has authored 88 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 36 papers in Small Animals and 16 papers in Surgery. Recurrent topics in R. Sapierzyński's work include Veterinary Oncology Research (40 papers), Infectious Diseases and Mycology (24 papers) and Virus-based gene therapy research (13 papers). R. Sapierzyński is often cited by papers focused on Veterinary Oncology Research (40 papers), Infectious Diseases and Mycology (24 papers) and Virus-based gene therapy research (13 papers). R. Sapierzyński collaborates with scholars based in Poland, Norway and Russia. R. Sapierzyński's co-authors include I. Dolka, Magdalena Król, Michał Czopowicz, Dariusz Jagielski, Urszula Jankowska, Katarzyna Dziendzikowska, Joanna Gromadzka-Ostrowska, Jacek Wilczak, Magdalena Kizerwetter‐Świda and P. Jurka and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

R. Sapierzyński

75 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Sapierzyński Poland 14 257 176 143 114 102 88 676
Anne M. Barger United States 17 287 1.1× 140 0.8× 127 0.9× 83 0.7× 99 1.0× 65 774
Elizabeth A. Carr United States 17 228 0.9× 148 0.8× 124 0.9× 50 0.4× 115 1.1× 35 892
Áureo Evangelista Santana Brazil 15 141 0.5× 199 1.1× 94 0.7× 47 0.4× 109 1.1× 91 774
Hiroo Madarame Japan 17 250 1.0× 83 0.5× 103 0.7× 309 2.7× 168 1.6× 101 961
Noeme Sousa Rocha Brazil 18 340 1.3× 207 1.2× 180 1.3× 66 0.6× 163 1.6× 171 1.1k
Mark V. Crisman United States 19 115 0.4× 338 1.9× 51 0.4× 98 0.9× 99 1.0× 70 1.1k
Niels Grützner United States 16 338 1.3× 210 1.2× 53 0.4× 126 1.1× 269 2.6× 42 756
Jon Teige Norway 15 221 0.9× 312 1.8× 126 0.9× 25 0.2× 122 1.2× 44 892
Mathilde Leclère Canada 17 127 0.5× 138 0.8× 31 0.2× 75 0.7× 123 1.2× 53 973
Kristen N. Kindrachuk United States 6 168 0.7× 49 0.3× 46 0.3× 54 0.5× 245 2.4× 7 803

Countries citing papers authored by R. Sapierzyński

Since Specialization
Citations

This map shows the geographic impact of R. Sapierzyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Sapierzyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Sapierzyński more than expected).

Fields of papers citing papers by R. Sapierzyński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Sapierzyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Sapierzyński. The network helps show where R. Sapierzyński may publish in the future.

Co-authorship network of co-authors of R. Sapierzyński

This figure shows the co-authorship network connecting the top 25 collaborators of R. Sapierzyński. A scholar is included among the top collaborators of R. Sapierzyński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Sapierzyński. R. Sapierzyński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dziendzikowska, Katarzyna, Joanna Gromadzka-Ostrowska, Jacek Wilczak, et al.. (2024). In Vivo Pro-Inflammatory Effects of Silver Nanoparticles on the Colon Depend on Time and Route of Exposure. International Journal of Molecular Sciences. 25(9). 4879–4879. 6 indexed citations
2.
Harasym, Joanna, et al.. (2024). Consumption of Feed Supplemented with Oat Beta-Glucan as a Chemopreventive Agent against Colon Cancerogenesis in Rats. Nutrients. 16(8). 1125–1125. 5 indexed citations
3.
Czopowicz, Michał, et al.. (2024). Prognostic role of the updated Kiel classification in canine high‐grade T‐cell lymphomas. Veterinary Medicine and Science. 10(4). e1398–e1398. 1 indexed citations
4.
Ziąbka, Magdalena, et al.. (2023). In Vitro and In Vivo Studies of Antibacterial Coatings on Titanium Alloy Implants for Veterinary Application. International Journal of Molecular Sciences. 24(9). 8114–8114. 8 indexed citations
5.
Jagielski, Dariusz, et al.. (2021). Demographic and clinical characteristics of dogs with centroblastic lymphoma. Veterinary World. 14(1). 49–55.
6.
Kaszewski, Jarosław, Sebastian Dąbrowski, Ł. Wachnicki, et al.. (2019). Transfer of orally administered ZnO:Eu nanoparticles through the blood–testis barrier: the effect on kinetic sperm parameters and apoptosis in mice testes. Nanotechnology. 30(45). 455101–455101. 21 indexed citations
7.
Sapierzyński, R., et al.. (2011). Helicobacter sp. microorganisms do not alter proliferative activity of gastric epithelial cells in naturally infected swine. Bulletin of the Veterinary Institute in Pulawy. 55(1). 2 indexed citations
8.
Szeleszczuk, P., et al.. (2011). Trichomoniasis, psittacine circovirosis and Clostridial infection in a budgeriger.. Medycyna Weterynaryjna. 67(2). 133–135. 1 indexed citations
9.
Sapierzyński, R., et al.. (2010). Analysis of haematological abnormalities observed in dogs infected by a large Babesia.. Bulletin of the Veterinary Institute in Pulawy. 54(2). 167–170. 13 indexed citations
10.
Dolka, I., et al.. (2010). Canine mammary tumors - a model for studying breast cancer in women.. Życie Weterynaryjne. 85(12). 965–971. 1 indexed citations
11.
Dolka, I., et al.. (2010). IGF-I and other growth factors in canine and human mammary tumors - their role in carcinogenesis and prognostic significance.. Medycyna Weterynaryjna. 66(11). 745–750. 2 indexed citations
12.
Sapierzyński, R.. (2009). Otitis externa in dogs.. Medycyna Weterynaryjna. 65(8). 552–556. 1 indexed citations
13.
Sapierzyński, R.. (2008). Nowotwory tkanki krwiotworczej u psow i kotow. Cz II. Chloniaki u kotow - przyczyny, postacie kliniczne i rozpoznawanie. Życie Weterynaryjne. 83(6). 462–468.
14.
Sapierzyński, R., et al.. (2007). Tumors of the urogenital system in dogs and cats. Retrospective review of 138 cases.. PubMed. 10(2). 97–103. 25 indexed citations
15.
Sapierzyński, R., et al.. (2007). Density and characteristics of inflammatory infiltration in gastric mucosa in swine with Helicobacter infections.. Medycyna Weterynaryjna. 63(9). 1102–1105. 1 indexed citations
16.
Sapierzyński, R., et al.. (2007). Oral tumors in dogs and cats: retrospective review of 143 cases.. Medycyna Weterynaryjna. 63(10). 1196–1199. 4 indexed citations
17.
Sapierzyński, R.. (2007). Nowotwory gruczolu sutkowego u psow i kotow. Czesc I. Wystepowanie, przyczyny, objawy kliniczne i wyglad makroskopowy. Życie Weterynaryjne. 82(2). 114–118.
18.
Sapierzyński, R., et al.. (2006). Preliminary data on Helicobacter sp. and candidatus Helicobacter suis infection rate in porcine gastric mucosa. Bulletin of the Veterinary Institute in Pulawy. 50(4). 445–449. 3 indexed citations
19.
Sapierzyński, R., et al.. (2006). Occurrence and clinical significance of the Helicobacter sp. microorganisms in swine.. Medycyna Weterynaryjna. 62(12). 1352–1356. 1 indexed citations
20.
Sapierzyński, R., et al.. (2004). Nowotwory mezenchymalne skory i tkanki podskornej u psow i kotow. Czesc IV. Miesaki poszczepienne u kotow. Życie Weterynaryjne. 79(10). 546–551.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne M. Barger Breakdown of academic impact, for papers by Elizabeth A. Carr Breakdown of academic impact, for papers by Áureo Evangelista Santana Breakdown of academic impact, for papers by Hiroo Madarame Breakdown of academic impact, for papers by Noeme Sousa Rocha Breakdown of academic impact, for papers by Mark V. Crisman Breakdown of academic impact, for papers by Niels Grützner Breakdown of academic impact, for papers by Jon Teige Breakdown of academic impact, for papers by Mathilde Leclère Breakdown of academic impact, for papers by Kristen N. Kindrachuk
Rankless by CCL
2026